Study title:
Eur Neurol. 1989;29 Suppl 3:16-24.
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging
and dementia. A decade of studies.
Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME.Eur Neurol. 1989;29 Suppl 3:16-24.
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging
and dementia. A decade of studies.
Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: V09I X04
|
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|